Weave Communications, Inc. (WEAV) stock intrinsic value fair value estimate & owner earnings analysis

Weave Communications sells a subscription software platform to small healthcare practices, mainly dental, optometry, veterinary and specialty medical offices. It combines phones, texting, scheduling, payments and reviews, and is adding AI features. At year-end 2025 it had nearly 40,000 locations and more than 30,000 customers in the United States and Canada, and no customer above 5% of revenue. Revenue has grown steadily: $116M in 2021, $142M in 2022, $170M in 2023, $204M in 2024 and $239M in 2025. Why we value the shares at $0 in all three cases. Our method counts what an owner could actually take out of the business each year: operating cash flow, minus swings in working capital, minus stock-based compensation (a real cost paid in shares instead of cash), minus the capital spending needed to keep the business running. For Weave that figure is negative in every year we measured (2021 to 2025). Per diluted share it was about -$2.57 in 2021, -$0.71 in 2022, -$0.45 in 2023, -$0.38 in 2024 and -$0.37 in 2025. In 2025 operating cash flow was $17.5M, but stock compensation was $32.1M and maintenance-level spending on equipment, capitalized software and finance-lease payments about $9.0M, leaving roughly -$28M. Owner earnings were about -$27M in 2024, so 2025 did not improve even though revenue grew 17%. We treat equipment acquired under finance leases (about $7M of principal repaid each year) as capital spending, and we treat commissions capitalized and later amortized as an ordinary operating cost rather than working capital. The company's own cash flow looks better than ours mainly because of stock compensation, which we do not add back. Bear, base and bull. We credit value only where growth or earnings are already secured or come from a repeatable record. Revenue growth is real, but it has not so far produced owner earnings: after stock compensation, the business has consumed roughly $27M to $30M a year in each of the last three years despite revenue rising by about $70M over that span. Profit-margin expansion, AI product success and further vertical expansion are management aims, not demonstrated results, so we do not credit them. With no evidenced route to positive owner earnings, all three cases come to $0 per share. This is not a claim that the company owes more than it is worth. It has no meaningful debt burden in the filings we reviewed beyond finance-lease obligations, and it repaid a $10M credit line in 2023. It reflects that today's shareholders are being paid for through dilution: diluted shares rose from about 65M in 2022 to about 76M in 2025 (79M in the first half of 2026). What we tested. The best evidence against this view is in the first half of 2026: stock compensation fell to $14.2M from $18.2M a year earlier, and the net loss narrowed to $10.0M from $17.5M. But operating cash flow was $4.5M against $5.2M, and two quarters of lower stock compensation is not yet a demonstrated pattern, so we did not raise any case on it. Acquisition of a business in 2025 (about $23.9M in cash plus $10.0M in shares) adds to the record of spending, and no benefit to owner earnings is visible yet. What would make this wrong. If stock compensation keeps falling while cash flow holds up and revenue growth continues, owner earnings could turn positive within a couple of years. The estimate would be revisited at that point. Until then we see nothing we can name and evidence that supports a positive value per share.